首页> 美国卫生研究院文献>ACS Omega >Mapping the Binding Hotspots and Transient Binding Pockets on V-Domain Immunoglobulin Suppressor of T Cell Activation Protein Surface
【2h】

Mapping the Binding Hotspots and Transient Binding Pockets on V-Domain Immunoglobulin Suppressor of T Cell Activation Protein Surface

机译:绘制 T 细胞活化蛋白表面 V 结构域免疫球蛋白抑制因子上的结合热点和瞬时结合口袋

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

V-domain immunoglobulin suppressor of T cell activation (VISTA), an inhibitory immune checkpoint present on both immune and tumor cells, has emerged as a highly promising target for cancer therapy due to its potential to overcome resistance encountered with existing immune checkpoint treatments. VSIG-3 is determined as an inhibitory ligand for VISTA, leading to the suppression of T cell proliferation. However, hotspots between VISTA/VSIG-3 protein–protein interaction remain ambiguous, mainly attributed to the lack of the structure of the VISTA/VSIG-3 complex. Therefore, in this study, in order to determine the energetic contributions of the interfacial residues on VISTA, we first constructed VISTA/VSIG-3 complex models by the protein docking method, followed by molecular dynamics simulations, binding free-energy decomposition, and alanine scanning. Results suggested that the putative hotspots in VISTA comprise residues His32, Tyr37, Thr35, Glu47, Val48, Gln49, Glu53, Arg54, Gln73, His122, and His126. Moreover, the distribution of the hotspots was clustered into two regions (hot regions I and II), and by using the TRAPP tool, transient subpockets within the hot regions were identified. Furthermore, conformational states of the binding pockets exhibiting druggability scores higher than those observed in the crystal structure were found. Overall, we hope that the findings outlined in this study can be used to facilitate the development of inhibitors targeting the VISTA/VSIG-3 immune checkpoint pathway in the future.
机译:T 细胞活化的 V 结构域免疫球蛋白抑制因子 (VISTA) 是一种存在于免疫细胞和肿瘤细胞上的抑制性免疫检查点,由于其有可能克服现有免疫检查点治疗遇到的耐药性,因此已成为癌症治疗的非常有前途的靶点。VSIG-3 被确定为 VISTA 的抑制配体,导致 T 细胞增殖受到抑制。然而,VISTA/VSIG-3 蛋白-蛋白质相互作用之间的热点仍然不明确,主要是由于缺乏 VISTA/VSIG-3 复合物的结构。因此,在本研究中,为了确定界面残基对 VISTA 的能量贡献,我们首先通过蛋白质对接方法构建了 VISTA/VSIG-3 复合物模型,然后进行了分子动力学模拟、结合自由能分解和丙氨酸扫描。结果表明,VISTA 中的假定热点包括残基 His32、Tyr37、Thr35、Glu47、Val48、Gln49、Glu53、Arg54、Gln73、His122 和 His126。此外,将热点的分布聚集在两个区域 (热区 I 和 II),并使用 TRAPP 工具识别热区内的瞬态子口袋。此外,发现结合口袋的构象状态表现出高于在晶体结构中观察到的成药性评分。总的来说,我们希望本研究中概述的结果可用于促进未来靶向 VISTA/VSIG-3 免疫检查点通路的抑制剂的开发。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号